Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.

Andrology - 1 Jul 2013

Morrison B F, Reid M, Madden W, Burnett A L

Abstract excerpt

Hypogonadism, which is highly prevalent in men with sickle cell disease (SCD), affects quality of life and causes great morbidity. The safety of testosterone replacement therapy (TRT) in SCD in relation to priapism episodes is relatively unknown. Our aim was to monitor the safety of TRT in a coho...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to Hemoglobin, Sickle
Share to Hormone Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypogonadism

Share to Injections, Intramuscular

Share to Jamaica

Share to Pilot Projects

Share to Testosterone

Source

Identifiers

PMID: 23606509
DOI: 10.1111/j.2047-2927.2013.00084.x

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23606509-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.PMID 23606509Read ↗

Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers.Semantic proximity Read ↗

Hemolysis-associated priapism in sickle cell disease.Semantic proximity Read ↗

Oral Testosterone Therapy in Hypogonadal Men: A Comprehensive Systematic Review and Meta-Analysis of Safety, Efficacy, and Secondary Health OutcomesSemantic proximity Read ↗

COMPENSATED HYPOGONADISM IN MEN WITH SICKLE CELL DISEASESemantic proximity Read ↗

The vulnerable man: impact of testosterone deficiency on the uraemic phenotype.Semantic proximity Read ↗

Genetic polymorphisms associated with priapism in sickle cell disease.Semantic proximity Read ↗

Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.Semantic proximity Read ↗

Effects of Age on Testicular Function and Consequences of Testosterone Treatment<sup>1</sup>Semantic proximity Read ↗

Review of 21 cases of priapism - management, results and the role of Hb genotype S in prognosis.Semantic proximity Read ↗

Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.